Literature DB >> 24748402

The mu opioid receptor activation does not affect ischemia-induced agonal currents in rat spinal ventral horn.

Hiroyuki Honda1, Hiroshi Baba, Tatsuro Kohno.   

Abstract

PURPOSE: Opioid-induced spastic paraplegia after transient spinal cord ischemia during aortic surgery has been reported. Opioids modulate neurotransmission through mu (μ) opioid receptors (MORs) in the spinal ventral horn. However, their effects during ischemic insult are not understood.
METHODS: The effects of the selective μ agonist [D-Ala(2),-N-Me-Phe(4), Gly(5)-ol]enkephalin (DAMGO) on ischemia-induced agonal currents were examined in the spinal lamina IX neurons of neonatal rats by using the whole-cell patch-clamp technique. Ischemia was simulated in vitro by oxygen/glucose deprivation.
RESULTS: DAMGO (1 μM) produced outward currents in ~60% of spinal lamina IX neurons at a holding potential of -70 mV. Superfusion with ischemia-simulating medium elicited an agonal current. The latency was 457 ± 18 s. Despite its neuromodulatory effects, DAMGO did not significantly change the latencies of the agonal currents with (440 ± 23 s) or without (454 ± 33 s) DAMGO-induced currents.
CONCLUSION: Activation of MORs does not influence ongoing ischemia-induced neuronal death. Our findings indicate that MOR agonist administration should be suitable as an anesthetic during aortic surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748402     DOI: 10.1007/s00540-014-1829-3

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  40 in total

Review 1.  Cellular and synaptic adaptations mediating opioid dependence.

Authors:  J T Williams; M J Christie; O Manzoni
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Comparative study of gene expression of cholinergic system-related molecules in the human spinal cord and term placenta.

Authors:  Y Oda; Y Muroishi; H Misawa; S Suzuki
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 3.  Cell signaling and neuronal death.

Authors:  Makoto R Hara; Solomon H Snyder
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin.

Authors:  M Yoshimura; R A North
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

5.  Selective vulnerability to ischemia in the rat spinal cord: a comparison between ventral and dorsal horn neurons.

Authors:  Kazuhiro Nohda; Terumasa Nakatsuka; Daisuke Takeda; Nobuyuki Miyazaki; Hideto Nishi; Hideki Sonobe; Munehito Yoshida
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-01       Impact factor: 3.468

6.  Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits.

Authors:  K P Madden
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

7.  Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons.

Authors:  Luigi Formisano; Kyung-Min Noh; Takahiro Miyawaki; Toshihiro Mashiko; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

8.  Naloxone in experimental spinal cord ischemia: dose-response studies.

Authors:  A I Faden; T P Jacobs; M T Smith; J A Zivin
Journal:  Eur J Pharmacol       Date:  1984-08-03       Impact factor: 4.432

9.  Hypothermia suppresses excitatory synaptic transmission and neuronal death induced by experimental ischemia in spinal ventral horn neurons.

Authors:  Hideto Nishi; Terumasa Nakatsuka; Daisuke Takeda; Nobuyuki Miyazaki; Junya Sakanaka; Hiroshi Yamada; Munehito Yoshida
Journal:  Spine (Phila Pa 1976)       Date:  2007-12-01       Impact factor: 3.468

10.  Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, mu-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors.

Authors:  S Kar; R Quirion
Journal:  J Comp Neurol       Date:  1995-04-03       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.